Stock comparison
Guardian Pharmacy Services
United Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GRDN
Guardian Pharmacy Services
Market cap
$2.44B
Sector
Healthcare
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GRDN | UTHR | Winner |
|---|---|---|---|
| Warren Buffett | 54C | 71B | UTHR |
| Benjamin Graham | 62D | 76B | UTHR |
| Philip Fisher | 57C | 76B | UTHR |
| Peter Lynch | 60C | 62C | UTHR |
| Joel Greenblatt | 61C | 46D | GRDN |
| Charlie Munger | 47D | 64C | UTHR |
| Terry Smith | 52C | 64C | UTHR |
Side-by-side metrics
| Metric | GRDN | UTHR |
|---|---|---|
| Market cap | $2.44B | $24.13B |
| P/E (TTM) | 42.7x | 19.2x |
| EV/EBIT | 30.8x | 15.2x |
| ROIC (TTM) | 20.71% | 18.81% |
| Gross margin | 20.93% | 86.58% |
| Net margin | 3.64% | 40.61% |
| Revenue CAGR 5y | 16.29% | 17.22% |
| EPS CAGR 5y | 30.79% | 29.84% |
| Debt / Equity | 0.2x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GRDN leads on
- ROIC (TTM)20.71%vs 18.81%+9%
UTHR leads on
- Debt / Equity-vs 0.2x+100%
- Net margin40.61%vs 3.64%+91%
- Market cap$24.13Bvs $2.44B+90%
- Gross margin86.58%vs 20.93%+76%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.